Looking back to 2023: advancement in epilepsy diagnosis and treatment
10.3760/cma.j.cn113694-20240124-00051
- VernacularTitle:回眸2023——癫痫诊疗研究进展
- Author:
Qun WANG
1
;
Shiwen WENG
;
Huajun YANG
;
Wei SHAN
Author Information
1. 首都医科大学附属北京天坛医院神经病学中心癫痫科 国家神经系统疾病临床研究中心，北京 100070
- Keywords:
Epilepsy;
Antiepileptic therapy;
Commentary
- From:
Chinese Journal of Neurology
2024;57(10):1037-1044
- CountryChina
- Language:Chinese
-
Abstract:
In 2023, significant progress was achieved in both basic and clinical research in the field of epilepsy, opening up new avenues and providing valuable insights which advance understanding of epilepsy. These advancements encompassed research on the mechanism of anti-epileptic seizure drugs, genomic research on the causes of epilepsy, cell gene therapy, exploration of the relationship between epilepsy and cognition, comparative research on the treatment of children and idiopathic epilepsy, as well as the development of new drugs and devices. These substantial progresses have contributed to a more comprehensive understanding of the complexity of epilepsy, provided identified targets for further basic research, and provided guidance for clinical diagnosis and treatment.
